Pharmacology of GLP-1 Receptor Agonists and DPP-4 Inhibitors (Antidiabetic Drugs) [ENGLISH] [yellow pill for weight loss]

Pharmacology of GLP-1 Receptor Agonists and DPP-4 Inhibitors (Antidiabetic Drugs) [ENGLISH] [yellow pill for weight loss]

| 1h 28m 28s | Video has closed captioning.

Pharmacology of GLP-1 Receptor Agonists and DPP-4 Inhibitors (Antidiabetic Drugs) [ENGLISH] by Dr. Shikha Parmar Diabetes mellitus is a disorder in which blood sugar (glucose) levels are abnormally high because the body does not produce enough insulin to meet its needs. Type 1 Diabetes Mellitus In type 1 diabetes (formerly called insulin-dependent diabetes or juvenile-onset diabetes), the body's immune system attacks the insulin-producing cells of the pancreas, and more than 90% of them are permanently destroyed. The pancreas, therefore, produces little or no insulin. Only about 5 to 10% of all people with diabetes have type 1 disease. Most people who have type 1 diabetes develop the disease before age 30, although it can develop later in life. Type 2 Diabetes Mellitus In type 2 diabetes (formerly called non– insulin-dependent diabetes or adult-onset diabetes), the pancreas often continues to produce insulin, sometimes even at higher-than-normal levels, especially early in the disease. However, the body develops resistance to the effects of insulin, so there is not enough insulin to meet the body’s needs. As type 2 diabetes progresses, the insulin-producing ability of the pancreas decreases. Complications of diabetes (1) Brain, causing a stroke (2) Eyes (diabetic retinopathy), causing blindness (3) Heart, causing a heart attack (4) Kidneys (diabetic nephropathy), causing chronic kidney disease (5) Nerves (diabetic neuropathy), causing a decreased sensation in feet Description Source: Wikipedia